Showing results (171-180 of 181) with videos related to

Sort By:
Pageof 19
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 2006
Efficacy of high-dose alkylating chemotherapy in HER2/neu-negative breast cancerS Rodenhuis, M Bontenbal, Q G C M van Hoesel, et al.
British Journal of Cancer|October 24, 2013
Neoadjuvant chemotherapy adaptation and serial MRI response monitoring in ER-positive HER2-negative breast cancerL S Rigter, C E Loo, S C Linn, et al.
Bone Marrow Transplantation|July 16, 2008
Factors influencing catheter-related infections in the Dutch multicenter study on high-dose chemotherapy followed by peripheral SCT in high-risk breast cancer patientsP Nieboer, E G E de Vries, N H Mulder, et al.
British Journal of Cancer|November 8, 2006
Molecular subtypes of breast cancer and amplification of topoisomerase II alpha: predictive role in dose intensive adjuvant chemotherapyJ Hannemann, P Kristel, H van Tinteren, et al.
Breast Cancer Research and Treatment|October 20, 2006
Tumor characteristics and detection method in the MRISC screening program for the early detection of hereditary breast cancerM Kriege, C T M Brekelmans, H Peterse, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2012
Growth modulation index as metric of clinical benefit assessment among advanced soft tissue sarcoma patients receiving trabectedin as a salvage therapyN Penel, G D Demetri, J Y Blay, et al.
Breast Cancer Research and Treatment|September 27, 2008
Validation of 70-gene prognosis signature in node-negative breast cancerJ M Bueno-de-Mesquita, S C Linn, R Keijzer, et al.
European Journal of Cancer (Oxford, England : 1990)|August 24, 2005
Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancerA C Voogd, F J van Oost, E J T Rutgers, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 8, 2010
An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patientsM A Vollebergh, E H Lips, P M Nederlof, et al.
British Journal of Cancer|January 16, 2014
Impact of rapid genetic counselling and testing on the decision to undergo immediate or delayed prophylactic mastectomy in newly diagnosed breast cancer patients: findings from a randomised controlled trialM R Wevers, N K Aaronson, S Verhoef, et al.
Pageof 19